Skip to main content
Caplight Logo









Proteinea

Proteinea

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.proteinea.com/

Last Round

Seed

Mar 14, 2022

Total Funding Raised

$4.75M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Proteinea is a biotechnology company that provides an AI-driven protein engineering platform for antibody-based therapeutic discovery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Foundation

Keywords

protein engineeringantibody engineeringAI for drug discoveryProtein Language ModelPLMfoundation modelgenerative biologyprotein designAnkhfrontier AI labbiotherapeuticsdrug development partnershipswet-lab validationcomputational biologyself-driving labFc domain engineering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Proteinea Comparables

Compare Proteinea with similar companies based on industry and business-model similarity.

Proteinea comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AI Proteins
89%
EvolutionaryScale
86%
BigHat Biosciences
84%

Proteinea Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 14, 2022
AcceleratorMar 17, 2021
AcceleratorFeb 16, 2020

Key People

Founding team and executive leadership

Abdulaziz Elgammal

Co-founder & CPO

Founding Team

Mahmoud Eljendy

Co-Founder & CEO

Founding Team

Proteinea Investors

Notable investors and investment history

Proteinea investors
InvestorRounds
Shorooq PartnersSeed
Flat6LabsAccelerator
500 GlobalSeed
Sawari VenturesSeed
Sadu CapitalSeed
VentureSouqSeed
SOSVAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 1111% MoM, reaching 1.8K.

  • Nov 12, 2024

    Monthly visitors increased 1068% MoM, reaching 2.5K.

Proteinea Filings

Explore SEC and related filing metadata, where available.

Proteinea filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Proteinea's valuation, stock price, and market status.

Is Proteinea a public or private company?

Proteinea is a private company.

What is the current stock price of Proteinea?

Proteinea is a private company with no public stock price. No recent secondary market data is available.

How much is Proteinea worth (valuation)?

Valuation information for Proteinea is not publicly available.

Can I buy Proteinea stock?

Proteinea shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Proteinea's last funding round?

Proteinea's most recent funding round was Seed on March 14, 2022.

Who are the main investors in Proteinea?

Key investors in Proteinea include Shorooq Partners, Sawari Ventures, SOSV.

Will Proteinea IPO soon?

No public IPO plans have been announced for Proteinea.

How can I track Proteinea secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Proteinea's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range47
Year Founded2019
Last FundingMar 14, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?